Evidence map›Paper›PMID 30636232›Full record

ArticleDevelopmental period medicine

Metabolic syndrome in overweight or obese children and adolescents based on own material Abstract Key words.

Katarzyna Szabelska-Zakrzewska, Alina Durko, Anna Socha-Banasiak, Małgorzata Majewska, Michał Kolejwa, Joanna Kazanek-Zasada, Elżbieta Czkwianianc

Open access · greenAbstract read
In one paragraph

Article in Developmental period medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Metabolic Syndrome in Obese Children-Clinical Prevalence and Risk Factors.International journal of environmental research and public health · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Katarzyna Szabelska-ZakrzewskaDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Alina DurkoDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Anna Socha-BanasiakDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Małgorzata MajewskaDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Michał KolejwaDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Joanna Kazanek-ZasadaDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Elżbieta CzkwianiancDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.
Polish Mother’s Memorial Hospital Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAim: To assess the prevalence of metabolic syndrome (MS) components in overweight or obese children and adolescents, as well as analyze the risk factors of its occurrence. PATIENTS AND

methodsMaterial and methods: The study was conducted in a group of 70 children and adolescents aged 5-18 hospitalized in the Department of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital - Research Institute in Lodz (Poland) based on the results of medical histories, physical examination, biochemical investigation, and calculation of the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index.

resultsResults: MS was diagnosed in 14 children (20%). The most common abnormalities besides obesity included: decreased High Density Lipoprotein Cholesterol (HDL-C) levels (n=13, 92.9%), increased triglycerides (TG) concentrations (n=10, 71.4%) and arterial hypertension (n=10, 71,4%). Among all the children, insulin resistance was diagnosed in 29 subjects (41.4%). The results of univariate logistic regression showed that the occurrence of lipid disorders, obesity, hypertension and diabetes in their parents, as well as the duration of pregnancy, birth weight, or breastfeeding were not associated with the risk of MS development in the subjects (p>0.05). However, in the study group, 92.9% of subjects had one or more particular risk factor for MS development.

conclusionConclusions: Besides visceral obesity, lipid disorders were the most frequently observed components of MS in the subjects analyzed, which may have prognostic significance. The occurrence of one or more MS risk factors in almost all of the children studied indicates the increased risk of cardiovascular diseases in the studied group in the future.

Indexed as

AdolescentBody Mass IndexChildChild, PreschoolFemaleHumansMaleMetabolic SyndromeObesityOverweightPolandPrevalenceRisk Factorschildrendiabeteslipid disordersmetabolic syndromeobesity

Identifiers

PMID30636232
PMCPMC8522824
OpenAlexW2990085102

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.